1. Home
  2. INMD

INMD

InMode Ltd.

Logo InMode Ltd.

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

as 04-19-2024 3:32pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

Founded: 2008 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 1.5B IPO Year: 2019
Target Price: $32.80 AVG Volume (30 days): 1.6M
Analyst Decision: Hold Number of Analysts: 6
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 2.30 EPS Growth: 21.69
52 Week Low/High: $17.74 - $48.25 Next Earning Date: 05-02-2024
Revenue: $492,048,000 Revenue Growth: 8.32%
Revenue Growth (this year): 3.39% Revenue Growth (next year): 7.91%

Share on Social Networks: